Therapy News and Research

RSS

Concordia Healthcare enters into definitive agreement to acquire Donnatal

Concordia Healthcare Corp., announced today that it has entered into a definitive agreement to acquire Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis, from a privately held specialty pharmaceutical company carrying on business as Revive Pharmaceuticals ("Revive Pharmaceuticals").

20 Mar 2014

Investigational vaccine reduces number of tumors in mice with lung cancer

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted the immune response and reduced the number of tumors in mice with lung cancer.

20 Mar 2014

Maturitas publishes EMAS' position statement on menopause curriculum for medical students

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of the essential menopause curriculum for medical students.

20 Mar 2014

Scientist receives $147,157 grant from NIH to find cure for infectious disease

A Clemson University scientist was awarded a two-year, $147,157 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find a cure for an infectious disease.

20 Mar 2014

Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions.

20 Mar 2014

Long-term survivors after esophagectomy with gastric pull-up can enjoy good quality of life

Long-term survivors after esophagectomy with gastric pull-up can enjoy a satisfying meal and good quality of life according to a new study from a team of researchers at the University of Southern California Keck School of Medicine, Los Angeles.

20 Mar 2014

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that preliminary top-line results of its Phase 3 clinical trial evaluating the safety and efficacy of its treatment for sickle cell anemia and sickle beta-0 thalassemia met both the primary and secondary endpoints of the clinical trial.

20 Mar 2014

New curricula is essential to train internists to manage menopausal symptoms

The number of menopausal women is projected to reach 50 million by 2020. With changing views on appropriate therapies to control symptoms and new treatments available and on the horizon, most internists lack the core competencies and experience to meet the needs of women entering menopause, according to a provocative Commentary published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

20 Mar 2014

Genetic testing may help select women with ER+ breast cancer for extended hormone therapy

Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five.

19 Mar 2014

Researchers discover potential new therapeutic target for controlling high blood sugar

A UT Southwestern Medical Center study has identified a new potential therapeutic target for controlling high blood sugar, a finding that could help the estimated 25 million Americans with type 2 diabetes.

19 Mar 2014

Lymphatic invasion indicates prognosis for lung cancer patients

The presence of lymphatic invasion indicates a worse prognosis for patients with pathologically node-positive lung adenocarcinoma, compared with its absence, indicate Japanese study findings.

19 Mar 2014

Renal mass biopsy rates increasing in kidney cancer

Rates of renal mass biopsy have been historically low in patients with kidney cancer, but are steadily rising, shows an analysis of Medicare data.

19 Mar 2014

Systemic stem cell therapy reduces malignant mesothelioma growth

Systemic delivery of stem cells expressing an apoptosis-inducing protein can successfully incorporate into malignant pleural mesothelioma cells and subsequently induce their death, according to preclinical study findings.

19 Mar 2014

Hint of survival benefit with bevacizumabpemetrexed maintenance for NSCLC

Updated data from the phase III AVAPERL trial hint that there might be an overall survival benefit of using bevacizumab in combination with pemetrexed as maintenance therapy in patients with advanced nonsmall cell lung cancer.

19 Mar 2014

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Using genomic analysis to study cancer in dogs can help develop new therapies for humans with cancer, according to a proof-of-concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (TGen).

19 Mar 2014

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Researchers at Case Western Reserve University and colleagues used "big data" analytics to predict if a patient is suffering from aggressive triple-negative breast cancer, slower-moving cancers or non-cancerous lesions with 95 percent accuracy.

19 Mar 2014

Study provides evidence that sepsis-related mortality has steadily decreased over time

In critically ill patients in Australia and New Zealand with severe sepsis or septic shock, there was a decrease in the risk of death from 2000 to 2012, findings that were accompanied by changes in the patterns of discharge of intensive care unit (ICU) patients to home, rehabilitation, and other hospitals, according to a study appearing in JAMA.

19 Mar 2014

Many community hospitals prescribe ineffective antibiotics for patients with bloodstream infections

Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.

19 Mar 2014

RaySearch signs distribution agreement with AlphaXRT for RayStation

RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.

19 Mar 2014

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.

19 Mar 2014

Therapy News and Research

Concordia Healthcare enters into definitive agreement to acquire Donnatal

Investigational vaccine reduces number of tumors in mice with lung cancer

Maturitas publishes EMAS' position statement on menopause curriculum for medical students

Scientist receives $147,157 grant from NIH to find cure for infectious disease

Elsevier launches Open Access, online-only journal Internet Interventions

Long-term survivors after esophagectomy with gastric pull-up can enjoy good quality of life

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

New curricula is essential to train internists to manage menopausal symptoms

Genetic testing may help select women with ER+ breast cancer for extended hormone therapy

Researchers discover potential new therapeutic target for controlling high blood sugar

Lymphatic invasion indicates prognosis for lung cancer patients

Renal mass biopsy rates increasing in kidney cancer

Systemic stem cell therapy reduces malignant mesothelioma growth

Hint of survival benefit with bevacizumabpemetrexed maintenance for NSCLC

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Study provides evidence that sepsis-related mortality has steadily decreased over time

Many community hospitals prescribe ineffective antibiotics for patients with bloodstream infections

RaySearch signs distribution agreement with AlphaXRT for RayStation

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News